FibroGen, Inc.
FGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,325 | $2,156 | $37,480 | $32,553 |
| - Cash | $50 | $114 | $156 | $171 |
| + Debt | $73 | $170 | $90 | $117 |
| Enterprise Value | $1,347 | $2,213 | $37,414 | $32,499 |
| Revenue | $30 | $47 | $141 | $235 |
| % Growth | -36.7% | -66.7% | -40.2% | – |
| Gross Profit | $14 | $43 | $120 | -$214 |
| % Margin | 47.5% | 91.5% | 85.6% | -90.9% |
| EBITDA | -$142 | -$305 | -$283 | -$334 |
| % Margin | -480.8% | -652.1% | -201% | -141.8% |
| Net Income | -$48 | -$284 | -$294 | -$290 |
| % Margin | -160.6% | -607.3% | -208.7% | -123.3% |
| EPS Diluted | -0.48 | -2.92 | -3.15 | -3.15 |
| % Growth | 83.6% | 7.3% | 0% | – |
| Operating Cash Flow | -$138 | -$315 | -$146 | -$82 |
| Capital Expenditures | -$0 | -$3 | -$39 | -$30 |
| Free Cash Flow | -$138 | -$318 | -$185 | -$112 |